Summary:
- This article discusses a new drug that has the potential to prevent up to 1 million new Alzheimer's cases per year, according to a recent study.
- The drug, called lecanemab, works by targeting and removing a protein called amyloid-beta, which is believed to be a key contributor to the development of Alzheimer's disease.
- The study found that lecanemab was able to slow the cognitive decline in people with early-stage Alzheimer's, suggesting that it could be an effective treatment for the disease if approved.